Edition:
India

ACADIA Pharmaceuticals Inc (ACAD.OQ)

ACAD.OQ on NASDAQ Stock Exchange Global Select Market

17.39USD
10:03pm IST
Change (% chg)

$-0.19 (-1.08%)
Prev Close
$17.58
Open
$17.45
Day's High
$17.58
Day's Low
$17.20
Volume
170,788
Avg. Vol
888,925
52-wk High
$41.20
52-wk Low
$14.52

Chart for

About

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for central nervous system (CNS) disorders. Its lead drug candidate, NUPLAZID (pimavanserin), is used for the treatment of hallucinations and delusions associated with Parkinson's disease... (more)

Overall

Beta: 3.76
Market Cap(Mil.): $4,717.31
Shares Outstanding(Mil.): 122.40
Dividend: --
Yield (%): --

Financials

BRIEF-Acadia Pharmaceuticals Q1 Loss Per Share $0.44

* ACADIA PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

04 May 2018

BRIEF-Acadia Pharmaceuticals Says CEO Stephen Davis's FY 2017 Total Compensation Was $15.2 Mln

* ACADIA PHARMACEUTICALS SAYS CEO STEPHEN DAVIS'S FY 2017 TOTAL COMPENSATION WAS $15.2 MILLION, INCLUDING $13.9 MILLION IN OPTION AWARDS - SEC FILING Source : https://bit.ly/2ra1j3J Further company coverage: (Reuters.Briefs@thomsonreuters.com)

01 May 2018

FDA says reviewing Acadia's Parkinson's medication, shares fall

WASHINGTON The U.S. Food and Drug Administration said on Wednesday it was reviewing Acadia Pharmaceuticals' Parkinson's medication, the only approved drug used to treat hallucinations and delusions associated with the disease.

26 Apr 2018

FDA says reviewing Acadia's Parkinson's medication, shares fall

WASHINGTON, April 25 The U.S. Food and Drug Administration said on Wednesday it was reviewing Acadia Pharmaceuticals' Parkinson's medication, the only approved drug used to treat hallucinations and delusions associated with the disease.

26 Apr 2018

BRIEF-Acadia Pharma Q4 Loss Per Share $0.55

* ACADIA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

28 Feb 2018

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $37.40 -0.25
Eli Lilly And Co (LLY.N) $89.32 -0.71
Eisai Co., Ltd (4523.T) ¥11,185 +220.00

Earnings vs. Estimates